Mads Gyrd-Hansen
@gyrd73
I am a group leader at Ludwig Cancer Research in Oxford. I am interested in ubiquitin signalling in immune responses and inflammation-associated cancer.
ID: 2371761339
28-02-2014 20:23:21
33 Tweet
203 Followers
0 Following
Our study on mechanism of RIPK2 inhibitors in ubiquitin-mediated inflammation is available at The EMBO Journal Congrats to Matous and Lisa! emboj.embopress.org/content/early/…
Oxford’s Covid-19 vaccine, devised by Sarah Gilbert, is in human trials. AstraZeneca has lined up agreements to produce 2 billion doses. Now the world waits bloomberg.com/news/features/… via Businessweek
Sascha Roth (@sasomroth) from the Sapkota Lab lab demonstrates targeted degradation of endogenous K-RAS. Read the full story here: ppu.mrc.ac.uk/news/sascha-ro… #research
Obituary for Tricia Cohen published in The Courier (Dundee) thecourier.co.uk/fp/news/local/…
#Ubiquitin regulation @MolecularCel #Met1-Linked Ub Machinery Ludwig Cancer Gyrd-Hansen Medical Sciences Mads Gyrd-Hansen cell.com/molecular-cell…
Congratulations to Ludwig’s Arshad Desai and Karen Oegema, newly appointed American Society for Cell Biology Fellows! goo.gl/wBQBXb
Congrats to Ludwig San Diego's Don Cleveland, who won the Breakthrough award for elucidating the cause of an inherited ALS and for developing "designer DNA" drugs for ALS and Huntington's disease UC San Diego Health goo.gl/SnG8Dk goo.gl/9T4zvv